Invasion and Metastasis Models for Studying RhoGDI2 in Bladder Cancer

Methods in Enzymology

Volumn 439, Issue , 2008, Pages 219-233

  Nitz, Matthew D ^a   Harding, Michael A ^a   Theodorescu, Dan ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROMEDIN U; RHOGD12 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; ARHGDIB PROTEIN, HUMAN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLADDER CANCER; CANCER CELL CULTURE; CANCER INVASION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR VOLUME; ANIMAL; ARTICLE; BLADDER; BLADDER TUMOR; DISEASE MODEL; LUNG TUMOR; METASTASIS; METHODOLOGY; ORGAN CULTURE TECHNIQUE; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; TUMOR CELL LINE;

MURINAE;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ORGAN CULTURE TECHNIQUES; RATS; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 45549107919     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)00417-X     Document Type: Review

References (40)

1. Bandyopadhyay A., Elkahloun A., Baysa S.J., Wang L., and Sun L.Z. Development and gene expression profiling of a metastatic variant of the human breast cancer MDA-MB-435 cells. Cancer Biol. Ther. 4 (2005) 168-174
2. Bubenik J., Baresova M., Viklicky V., Jakoubkova J., Sainerova H., and Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int. J. Cancer 11 (1973) 765-773
3. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2 (2002) 563-572
4. Chen X., Su Y., Fingleton B., Acuff H., Matrisian L.M., Zent R., and Pozzi A. Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. Int. J. Cancer 116 (2005) 52-61
5. Clark E.A., Golub T.R., Lander E.S., and Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (2000) 532-535
6. Crook T.J., Hall I.S., Solomon L.Z., Birch B.R., and Cooper A.J. A model of superficial bladder cancer using fluorescent tumour cells in an organ-culture system. BJU Int. 86 (2000) 886-893
7. del Peso L., Hernandez-Alcoceba R., Embade N., Carnero A., Esteve P., Paje C., and Lacal J.C. Rho proteins induce metastatic properties in vivo. Oncogene 15 (1997) 3047-3057
8. DerMardirossian C., and Bokoch G.M. GDIs: Central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15 (2005) 356-363
9. Dovas A., and Couchman J.R. RhoGDI: Multiple functions in the regulation of Rho family GTPase activities. Biochem. J. 390 (2005) 1-9
10. Dransart E., Olofsson B., and Cherfils J. RhoGDIs revisited: Novel roles in Rho regulation. Traffic 6 (2005) 957-966
11. Faure J., and Dagher M.C. Interactions between Rho GTPases and Rho GDP dissociation inhibitor (Rho-GDI). Biochimie 83 (2001) 409-414
12. Fidler I.J. Selection of successive tumour lines for metastasis. Nat. New Biol. 242 (1973) 148-149
13. Gildea J.J., Golden W.L., Harding M.A., and Theodorescu D. Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer. Genes Chromosomes Cancer 27 (2000) 252-263
14. Gildea J.J., Herlevsen M., Harding M.A., Gulding K.M., Moskaluk C.A., Frierson H.F., and Theodorescu D. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 23 (2004) 6788-6797
15. Gildea J.J., Seraj M.J., Oxford G., Harding M.A., Hampton G.M., Moskaluk C.A., Frierson H.F., Conaway M.R., and Theodorescu D. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res. 62 (2002) 6418-6423
16. Gomez del Pulgar T., Benitah S.A., Valeron P.F., Espina C., and Lacal J.C. Rho GTPase expression in tumourigenesis: Evidence for a significant link. Bioessays 27 (2005) 602-613
17. Gorvel J.P., Chang T.C., Boretto J., Azuma T., and Chavrier P. Differential properties of D4/LyGDI versus RhoGDI: Phosphorylation and rho GTPase selectivity. FEBS Lett. 422 (1998) 269-273
18. Gupta G.P., and Massague J. Cancer metastasis: Building a framework. Cell 127 (2006) 679-695
19. Hall A. Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 33 (2005) 891-895
20. Isseroff R.R., Ziboh V.A., Chapkin R.S., and Martinez D.T. Conversion of linoleic acid into arachidonic acid by cultured murine and human keratinocytes. J. Lipid Res. 28 (1987) 1342-1349
21. Kamai T., Tsujii T., Arai K., Takagi K., Asami H., Ito Y., and Oshima H. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res. 9 (2003) 2632-2641
22. Kusama T., Mukai M., Endo H., Ishikawa O., Tatsuta M., Nakamura H., and Inoue M. Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cancer cell invasion and metastasis. Cancer Sci. 97 (2006) 848-853
23. Madaule P., and Axel R. A novel ras-related gene family. Cell 41 (1985) 31-40
24. Nicholson B.E., Frierson H.F., Conaway M.R., Seraj J.M., Harding M.A., Hampton G.M., and Theodorescu D. Profiling the evolution of human metastatic bladder cancer. Cancer Res. 64 (2004) 7813-7821
25. Opgenorth T.J., Adler A.L., Calzadilla S.V., Chiou W.J., Dayton B.D., Dixon D.B., Gehrke L.J., Hernandez L., Magnuson S.R., Marsh K.C., Novosad E.I., Von Geldern T.W., et al. Pharmacological characterization of A-127722: An orally active and highly potent ETA-selective receptor antagonist. J. Pharmacol. Exp. Ther. 276 (1996) 473-481
26. Ridley A.J., and Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70 (1992) 389-399
27. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., and Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70 (1992) 401-410
28. Sahai E., and Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2 (2002) 133-142
29. Seraj M.J., Harding M.A., Gildea J.J., Welch D.R., and Theodorescu D. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin. Exp. Metastasis 18 (2000) 519-525
30. Steeg P.S. Tumor metastasis: Mechanistic insights and clinical challenges. Nat. Med. 12 (2006) 895-904
31. Suwa H., Ohshio G., Imamura T., Watanabe G., Arii S., Imamura M., Narumiya S., Hiai H., and Fukumoto M. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer 77 (1998) 147-152
32. Theodorescu D., Cornil I., Fernandez B.J., and Kerbel R.S. Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma. Proc. Natl. Acad. Sci. USA 87 (1990) 9047-9051
33. Theodorescu D., Sapinoso L.M., Conaway M.R., Oxford G., Hampton G.M., and Frierson Jr. H.F. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin. Cancer Res. 10 (2004) 3800-3806
34. Titus B., Frierson Jr. H.F., Conaway M., Ching K., Guise T., Chirgwin J., Hampton G., and Theodorescu D. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. Cancer Res. 65 (2005) 7320-7327
35. Titus B., Schwartz M.A., and Theodorescu D. Rho proteins in cell migration and metastasis. Crit. Rev. Eukaryot. Gene Expr. 15 (2005) 103-114
36. van Golen K.L., Davies S., Wu Z.F., Wang Y., Bucana C.D., Root H., Chandrasekharappa S., Strawderman M., Ethier S.P., and Merajver S.D. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin. Cancer Res. 5 (1999) 2511-2519
37. Wang W., Yang L.Y., Yang Z.L., Huang G.W., and Lu W.Q. Expression and significance of RhoC gene in hepatocellular carcinoma. World J. Gastroenterol. 9 (2003) 1950-1953
38. Welch D.R. Technical considerations for studying cancer metastasis in vivo. Clin. Exp. Metastasis 15 (1997) 272-306
39. Wu Y., McRoberts K., Berr S.S., Frierson Jr. H.F., Conaway M., and Theodorescu D. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene 26 (2007) 765-773
40. Yang X., Wei L.L., Tang C., Slack R., Mueller S., and Lippman M.E. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res. 61 (2001) 5284-5288